Damien Fleury is a senior R&D professional with over than 15 years of Life Sciences industries experience. Damien held various leading research positions and played a key role in delivering preclinical candidates in the field of cachexia, osteoarthritis and rheumatoid arthritis at Proskelia (2002-2004), Prostrakan (2004-2006) and Galapagos (2007-2012). As associate research director at Addex Therapeutics (2012-2013, Geneva), he developed an externalized structure based drug discovery platform, selecting and negotiating contracts with international partners. Damien followed the startup training program of Linksium (Grenoble) in business development, finances and HR (2014-2016). Damien holds a PhD in molecular biophysics from Université Pierre et Marie Curie (Paris VI, Paris).
Sarah Milgram is a confirmed researcher with over than six years of experience in both fundamental and technological research for life sciences. After studies in in vitro evaluation of metals toxicity, Sarah developed original approaches for the capture, culture and analysis of living immune cells on biosensors during post-doctoral experiences at the French Alternative Energies and Atomic Energy Commission. Her fields of expertise range from cellular biology, in vitro toxicology evaluation to microsystem design, biosensors and lab-on-a-chip based immunoassays. Sarah holds a PhD in cellular and molecular biology from Université Jean Monnet (Saint-Étienne) and is an engineer in biomaterials and biomechanics from Université Technologique de Compiègne.
Formerly chairman of the Department ‘Poison Center and Pharmacovigilance’ of Lyon University General Hospitals, and head of the Laboratory of Fundamental and Clinical Immunotoxicology at Lyon University and INSERM, Professor Jacques Descotes is the author or co-author of 13 books, 78 chapters, 247 original scientific papers, 482 presentations and posters at international scientific meetings and congresses, making him an international KOL on topics related to preclinical and clinical/medical toxicology, immunotoxicology and regulatory risk assessment.
Yoann Roupioz is a specialist of biochips. He was the recipient of the “Young Researcher Award” of the French Biochemical and Molecular Biology Society (2007) and the Masao Horiba Award” in Kyoto, Japan (2011) and also a member of the “Nano and micro technologies for Biology” strategic watch group of the OMNT (2008 – 2013). His fields of expertise are ranging from conjugation chemistry, biomolecule handling for biosensing applications to the design and fabrication of functional cellular biochips for biomedical and food safety applications. He is co-founder of the Prestodiag company (Villejuif, France), launched in 2012.
Patrice Marche is an immunologist leading the team “Analytic immunology of Chronic Diseases” as a scientific director. He participated to several collaborative projects (ANR, European Community, FUI …) dedicated to the evaluation of the effects of nano materials and particles on the functions of the immune system. He is the author of 4 patents, leading to the creation of 2 new companies and published about 150 scientific articles aiming to decipher immune mechanisms in chronic pathologies and to propose innovations to detect and to cure diseases associated with chronic immune dysfunctions.